The newly published report by IMARC Group, titled ”Psychosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the psychosis market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
Request a Sample Report: https://www.imarcgroup.com/psychosis-market/requestsample
Psychosis Market Size:
The 7 major psychosis markets are expected to exhibit a CAGR of 4.88% during 2023-2033.
What is psychosis market?
Psychosis is a mental health disorder characterized by a disconnection from reality, resulting in substantial disturbances in an individual's thoughts, perceptions, emotions, and behaviors. Patients with psychosis often struggle to differentiate reality from illusion, leading to hallucinations (perceiving nonexistent things) and delusions (strongly held erroneous beliefs). Besides this, these patients might exhibit disorganized thinking and speech, social withdrawal, diminished motivation, and cognitive impairments. The diagnosis of psychosis entails an exhaustive evaluation of the patient's symptoms, medical history, and familial history of mental health disorders by a psychiatrist or a clinical psychologist. Diagnostic guidelines from recognized classification systems such as the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) are employed. The healthcare provider might conduct interviews, psychological tests, and observations to gather information and ascertain if the patient meets the criteria for psychosis.
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/psychosis-market
What are the key drivers and trends in the psychosis market?
The surge in mental health disorders such as schizophrenia, bipolar disorder, and severe depression, which can interfere with normal brain functions, is the primary driver of the psychosis market. Furthermore, the increasing prevalence of several associated risk factors, such as sleep disorders, postpartum complications, genetic predispositions, substance abuse, and neurodegenerative diseases, is creating a positive landscape for the market. Besides this, the widespread use of conventional antipsychotics, such as haloperidol and chlorpromazine, that target the brain's dopamine receptors, thereby reducing hallucinations, delusions, and disorganized thinking, is propelling the market forward.
Moreover, the escalating implementation of cognitive behavioral therapy, helping develop coping mechanisms, enhance problem-solving skills, and manage stress in patients, is contributing to the market's growth. Furthermore, the increasing application of mindfulness-based interventions, such as mindfulness-based cognitive therapy (MBCT) and mindfulness-based stress reduction (MBSR), for reducing stress levels, improving emotional regulation, and enhancing overall well-being, is aiding in market expansion.
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the psychosis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the psychosis market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Key Questions Answered in this Report:
- How has the psychosis market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the psychosis market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the psychosis market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
How This Report Can Help You:
- The report on psychosis market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
- With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the psychosis market.
- The psychosis market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
- Our report on the psychosis market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800